Core Viewpoint - MicroTech Medical-B (02235.HK) announced the grant of a total of 3.3 million shares to 51 qualified individuals under its share incentive plan adopted on December 24, 2025, with the shares pending acceptance by the grantees [1] Company Summary - As of December 30, 2025, MicroTech Medical-B closed at HKD 7.93, up 2.72%, with a trading volume of 57,000 shares and a turnover of HKD 444,000 [1] - The stock has a market capitalization of HKD 1.282 billion, ranking 18th in the medical device II industry [1] Investment Ratings - The majority of investment banks have a buy rating for MicroTech Medical-B, with one bank issuing a buy rating in the last 90 days [1] - CITIC Securities recently provided a buy rating for MicroTech Medical-B [1] Key Financial Metrics - Return on Equity (ROE): -1.36%, compared to the industry average of -4.85%, ranking 19th [1] - Market capitalization: HKD 1.282 billion, with the industry average at HKD 5.097 billion, ranking 18th [1] - Revenue: HKD 441 million, with the industry average at HKD 1.2 billion, ranking 17th [1] - Net Profit Margin: -0.93%, compared to the industry average of -19.0%, ranking 17th [1] - Gross Margin: 51.66%, with the industry average at 54.03%, ranking 17th [1] - Debt Ratio: 10.8%, compared to the industry average of 29.53%, ranking 5th [1]
微泰医疗-B(02235.HK)授出合共330万股奖励股份